Iopromide
- Generic Name
- Iopromide
- Brand Names
- Ultravist
- Drug Type
- Small Molecule
- Chemical Formula
- C18H24I3N3O8
- CAS Number
- 73334-07-3
- Unique Ingredient Identifier
- 712BAC33MZ
- Background
Iopromide is a low osmolar, non-ionic X-ray contrast agent for intravascular administration. It functions as a contrast agent by opacifying blood vessels in the flow path of the contrast agent, permitting radiographic visualization of the internal structures until significant hemodilution occurs. Although iopromide can cause several serious adverse effects, ...
- Indication
Iopromide, as the product IOVIST, is approved by the FDA for use as an intra-arterial or intravenous X-ray contrast agent. For intra-arterial administration, iopromide is indicated for cerebral arteriography, peripheral arteriography, coronary arteriography, left ventriculography, visceral angiography, and aortography in adults and radiographic evaluation of...
- Associated Conditions
- Breast Lesions, Neoplastic lesion, Non-neoplastic lesion
- Associated Therapies
- -
Iodine Supplementation on Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- Universidad Nacional Autonoma de Mexico
- Target Recruit Count
- 120
- Registration Number
- NCT03688958
- Locations
- 🇲🇽
Hospital Médico TEC100, Querétaro City, Queretaro, Mexico
🇲🇽ClÃnica Hospital Dr. Ismael Vázquez Ortiz ISSSTE, Querétaro, Queretaro, Mexico
🇲🇽Hospital General Regional #1 IMSS, Querétaro, Queretaro, Mexico
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
- Conditions
- Interventions
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT03631771
Vaginal Preparation Prior to Hysterectomy
- First Posted Date
- 2018-01-26
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT03412734
- Locations
- 🇺🇸
Good Samaritan Hospital, Cincinnati, Ohio, United States
The Amputation Surgical Site Infection Trial (ASSIT)
- Conditions
- Interventions
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2019-07-15
- Lead Sponsor
- Hull University Teaching Hospitals NHS Trust
- Target Recruit Count
- 160
- Registration Number
- NCT02018094
- Locations
- 🇬🇧
Hull Royal Infirmary, Hull, United Kingdom
Role of Perfusion CT in Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT01703650
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
- First Posted Date
- 2012-04-18
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Yong Huo
- Target Recruit Count
- 200
- Registration Number
- NCT01580046
- Locations
- 🇨🇳
The First Affiliated Hospital Of Guangxi Medical University, Nanning, Guangxi, China
🇨🇳Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳Pla Navy General Hospital, Beijing, China
Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
- Conditions
- Interventions
- First Posted Date
- 2010-12-07
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 468
- Registration Number
- NCT01255722
- Locations
- 🇫🇷
CHU Rouen - Hopital Charles Nicolle, Rouen, France
🇫🇷La Timone Adultes, Marseille, France
🇫🇷Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
Clinical Research Study Efficacy of a Prototype Oral Rinse
- First Posted Date
- 2009-11-26
- Last Posted Date
- 2009-12-01
- Lead Sponsor
- Colgate Palmolive
- Target Recruit Count
- 67
- Registration Number
- NCT01021007
- Locations
- 🇺🇸
New Institutional Service Company, Northfield, New Jersey, United States
Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)
- Conditions
- Interventions
- First Posted Date
- 2009-01-23
- Last Posted Date
- 2010-11-16
- Lead Sponsor
- Ospedale San Donato
- Target Recruit Count
- 432
- Registration Number
- NCT00827788
- Locations
- 🇮🇹
Cardiovascular Department, Ospedale S.Donato, Arezzo, AR, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.